{"id":"https://openalex.org/A5044133003","orcid":null,"observed_orcids":[],"display_name":"Maxwell Adu-Poku","raw_author_names":["Maxwell Adu-Poku"],"full_name":"Maxwell Adu-Poku","works_count":1,"cited_by_count":5,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5044133003","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I28046988","ror":"https://ror.org/00cb23x68","display_name":"Kwame Nkrumah University of Science and Technology","country_code":"GH","type":"education","lineage":["https://openalex.org/I28046988"]},"years":[2020]}],"last_known_institutions":[{"id":"https://openalex.org/I28046988","ror":"https://ror.org/00cb23x68","display_name":"Kwame Nkrumah University of Science and Technology","country_code":"GH","type":"education","lineage":["https://openalex.org/I28046988"]}],"topics":[{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","count":1,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","count":1,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11232","display_name":"Urinary Tract Infections Management","count":1,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11232","display_name":"Urinary Tract Infections Management","value":4.7e-06,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","value":3e-06,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","value":2.3e-06,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"2777427914","wikidata":"https://www.wikidata.org/wiki/Q408529","display_name":"Amikacin","score":0.8090623021125793},{"id":"2775832221","wikidata":"https://www.wikidata.org/wiki/Q422482","display_name":"Gentamicin","score":0.5075451135635376},{"id":"2775876089","wikidata":"https://www.wikidata.org/wiki/Q281082","display_name":"Nalidixic acid","score":0.49683359265327454},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.3903060853481293},{"id":"104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","score":0.0}],"counts_by_year":[{"year":2020,"works_count":1,"oa_works_count":1,"cited_by_count":5}],"display_name_alternatives":["Maxwell Adu-Poku"],"block_key":"m adu-poku","works_api_url":"https://api.openalex.org/works?filter=author.id:A5044133003","updated_date":"2026-10-07T12:33:31","created_date":"2025-10-10T00:00:00"}